StockData
CNBXOTCPharmaceutical PreparationsFiscal year ends August 31

CNBX Pharmaceuticals Inc.

Financials through Q3 FY2026, quarter ended May 31, 2026Last filing: 10-Q on Jun 24, 2026
$0.00+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$197.79K
P/E (TTM)
–
Dividend yield
–

Ownership

Who owns CNBX Pharmaceuticals's shares

Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
3i, LP169,341,4009.90%13G (passive) amendmentJun 30, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Inc. Cannabics
10% owner
Jul 25, 2014Sale+18,239,594––88,289,594
Inc. Cannabics
10% owner
Jun 23, 2014Sale+14,525,000$0.01$145.25K35,025,000
Inc. Cannabics
10% owner
May 8, 2014Sale+20,500,000$0.01$205.00K20,500,000
Thomas E. Mills
10% owner
May 8, 2014Sale−20,500,000$0.01$205.00K3
Thomas E. Mills
10% owner
Apr 25, 2014Sale+20,500,000$0.01$205.00K0
Thomas E. Mills
10% owner
Oct 28, 2013Buy+20,000,000$0.01$200.00K20,500,003
Thomas E. Mills
10% owner
Oct 28, 2013Buy+20,000,000$100000.00$2.00T20,510,000
Thomas E. Mills
10% owner
Jun 28, 2013Other−20,000,000$0.01$200.00K510,000
Thomas E. Mills
10% owner
Jun 24, 2013Buy+20,000,000$0.01$200.00K20,510,000
American Mining Corp North
10% owner
Nov 8, 2011Other−31,000,000––0
Lou Hilford
10% owner
Sep 25, 2007Sale−2,000,000––0
Thomas E. Mills
President, CEO, CFO, Director, 10% owner
Sep 25, 2007Buy+2,000,000––10,000,000

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.